Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Cancer Research

• Publication date

  2010-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-09-1800PMID 20442299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts

  2009cited by this paper
• Rational Combinations Using HDAC Inhibitors

  2009cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells

  2008cited by this paper
• Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

  2008cited by this paper
• CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

  2008cited by this paper
• PPARγ agonists inhibit growth and expansion of CD133+ brain tumour stem cells

  2008cited by this paper
• Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria

  2008cited by this paper
• Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme

  2008cited by this paper
• Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

  2008cited by this paper
• Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

  2008cited by this paper
• Developmental signaling pathways in brain tumor‐derived stem‐like cells

  2007cited by this paper
• Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo

  2007cited by this paper
• Cannabinoids Induce Glioma Stem-like Cell Differentiation and Inhibit Gliomagenesis*

  2007cited by this paper
• Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity.

  2007cited by this paper
• CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

  2007cited by this paper
• Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo

  2007cited by this paper
• Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name?

  2007cited by this paper
• Tumorigenesis of Chemotherapeutic Drug-Resistant Cancer Stem-Like Cells in Brain Glioma

  2007cited by this paper
• Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis

  2007cited by this paper
• Comparative analysis of in vitro conditions for rat adult neural progenitor cells.

  2007influential reference
• Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.

  2006cited by this paper
• Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells

  2006cited by this paper
• Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

  2006cited by this paper
• Different angiogenic phenotypes in primary and secondary glioblastomas

  2006cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

  2006influential reference
• Cancer stem cells and radiotherapy: new insights into tumor radioresistance.

  2006cited by this paper
• The expression of matrix metalloproteinase-2 and-9 in human gliomas of different pathological grades

  2006cited by this paper
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006cited by this paper
• Tumour stem cell-targeted treatment: elimination or differentiation.

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.

  2005cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Cancer stem cells: are we missing the target?

  2004cited by this paper
• Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.

  2004cited by this paper
• Vascular microenvironment in gliomas.

  2004cited by this paper
• Maintenance Therapy with 13-cis Retinoid Acid in High-Grade Glioma at Complete Response After First-Line Multimodal Therapy – A Phase-II Study

  2004cited by this paper
• All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway.

  2003cited by this paper
• Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

  2003cited by this paper
• Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells.

  2002cited by this paper
• Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• The Role of Epigenetic Modifications in Retinoic Acid Receptor β2 Gene Expression in Human Prostate Cancers

  2001cited by this paper
• Vascular Microenvironment in Gliomas

  2000cited by this paper
• All-trans-retinoic acid: a phase II radiation therapy oncology group study (RTOG 91-13) in patients with recurrent malignant astrocytoma

  1997cited by this paper
• The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin)

  1997cited by this paper
• All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications

  1997cited by this paper
• Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling.

  1994cited by this paper
• Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries

  1988cited by this paper
• Open access, freely available online Research in Translation Retinoic Acid and Arsenic for Treating Acute Promyelocytic

  year unknowncited by this paper

• Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation.

  2026cites this paper
• SHH pathway inhibition and astrocyte co-culture induce distinct responses in glioblastoma and cancer stem cells

  2026cites this paper
• All-Trans Retinoic Acid Induces Differentiation and Downregulates Stemness Markers and MGMT Expression in Glioblastoma Stem Cells

  2025cites this paper
• Radiation-induced cellular plasticity primes glioblastoma for forskolin-mediated differentiation

  2025cites this paper
• Beyond eradication: Therapeutic reprogramming strategies for cancer normalization (Review).

  2025cites this paper
• SHH Pathway Inhibition and Astrocyte Co-culture Induce Distinct Responses in Glioblastoma and Cancer Stem Cells

  2025cites this paper
• A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29

  2025cites this paper
• Progenitor cells, microglia, and non-coding RNAs: Orchestrators of glioblastoma pathogenesis and therapeutic resistance

  2025cites this paper
• Cancer stem cell heterogeneity‑inspired therapeutics for enhancing tumor treatment outcomes (Review).

  2025cites this paper
• N-Heterocyclic carbene platinum complexes encapsulated in lipid particles: a novel strategy to target cancer cells and cancer stem cells in glioblastoma

  2025cites this paper
• BRAT1 - a new therapeutic target for glioblastoma

  2024cites this paper
• Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy

  2024cites this paper
• Advances in ovarian tumor stem cells and therapy

  2024cites this paper
• Cleavage of the vascular matrix attracts glioblastoma cells to infiltrate the brain parenchyma

  2024cites this paper
• SOX10 mediates glioblastoma cell-state plasticity

  2024cites this paper
• Radiation-Induced Cellular Plasticity: A Strategy for Combatting Glioblastoma

  2024cites this paper
• Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.

  2023cites this paper
• Targeting fatty acid oxidation via Acyl-CoA binding protein hinders glioblastoma invasion

  2023cites this paper
• Combining organotypic tissue culture with light‐sheet microscopy (OTCxLSFM) to study glioma invasion

  2023cites this paper
• Triphenylphosphonium-functionalized N-heterocyclic carbene platinum complexes [(NHC-TPP+)Pt] induce cell death of human glioblastoma cancer stem cells.

  2023cites this paper
• Combining organotypic tissue culture with multi-color fluorescence light-sheet microscopy (OTCxLSFM) – a novel tool to study glioma invasion/migration

  2023cites this paper
• Transforming cancer cells for long-term living with cancer: An inspiring new approach.

  2023cites this paper
• Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells

  2023cites this paper
• The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells

  2023cites this paper
• Evaluation of the Cytotoxicity of Cationic Polymers on Glioblastoma Cancer Stem Cells

  2022cites this paper
• Polyethylenimine, an Autophagy-Inducing Platinum-Carbene-Based Drug Carrier with Potent Toxicity towards Glioblastoma Cancer Stem Cells

  2022cites this paper
• An N-heterocyclic carbene iridium(III) complex as a potent anti-cancer stem cell therapeutic.

  2022cites this paper
• Enzymatic activity of glycosyltransferase GLT8D1 promotes human glioblastoma cell migration

  2022cites this paper
• Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers

  2022cites this paper
• Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis

  2022cites this paper
• PFKFB4 interacts with FBXO28 to promote HIF-1α signaling in glioblastoma

  2022cites this paper
• CHRDL1 Regulates Stemness in Glioma Stem-like Cells

  2022cites this paper
• Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma

  2022cites this paper
• Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation

  2022cites this paper
• A yes-associated protein 1- Notch1 receptor positive feedback loop promotes breast cancer lung metastasis by attenuating the bone morphogenetic protein 4-SMAD family member 1/5 signaling

  2022cites this paper
• STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death

  2022influential citation
• Antitumor Effects of a New Retinoate of the Fungal Cytotoxin Illudin M in Brain Tumor Models

  2022cites this paper
• Roles of apelin/APJ system in cancer: Biomarker, predictor, and emerging therapeutic target

  2022cites this paper
• Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs

  2022cites this paper
• Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma Cells

  2022cites this paper
• Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy

  2021cites this paper
• Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research

  2021cites this paper
• TGFβ/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity

  2021cites this paper
• Enzymatic Activity of Glycosyltransferase Glt8d1 Promotes Human Glioblastoma Cells Migration

  2021cites this paper
• The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment

  2021cites this paper
• Modulating cell differentiation in cancer models.

  2021cites this paper
• Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide

  2021cites this paper
• A New Pentafluorothio-Substituted Curcuminoid with Superior Antitumor Activity

  2021influential citation
• FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma

  2021cites this paper
• BRAT1 depletion impairs DNA damage repair in glioblastoma cell lines

  2021cites this paper
• Targeting the Regulatory Subunit R2Alpha of Protein Kinase A in Human Glioblastoma through shRNA-Expressing Lentiviral Vectors

  2021cites this paper
• TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progression.

  2021cites this paper
• XAB2 promotes Ku eviction from single-ended DNA double-strand breaks independently of the ATM kinase

  2021cites this paper
• ERK Phosphorylation Regulates the Aml1/Runx1 Splice Variants and the TRP Channels Expression during the Differentiation of Glioma Stem Cell Lines

  2021cites this paper
• Nanog maintains stemness of Lkb1‐deficient lung adenocarcinoma and prevents gastric differentiation

  2021cites this paper
• Post-transcriptional repression of circadian component CLOCK regulates cancer-stemness in murine breast cancer cells

  2021cites this paper
• Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.

  2021cites this paper
• Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives

  2021cites this paper
• Dilation of Brain Veins and Perivascular Infiltration by Glioblastoma Cells in an In Vivo Assay of Early Tumor Angiogenesis

  2021cites this paper
• Evaluation of a DNA demethylating agent in combination with all-trans retinoic acid for IDH1-mutant gliomas.

  2021cites this paper
• Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells.

  2021cites this paper
• CRISPR-to-Kill (C2K)–Employing the Bacterial Immune System to Kill Cancer Cells

  2021cites this paper
• Integrated Metabolomics and Transcriptomics Analysis of Monolayer and Neurospheres from Established Glioblastoma Cell Lines

  2021cites this paper
• Molecular Targeting of Breast Cancer Stem Cells: A Promising Strategy For Management And Eradication

  2021cites this paper
• Phytol Down-Regulates Expression of Some Cancer Stem Cell Markers and Decreases Side Population Proportion in Human Embryonic Carcinoma NCCIT Cells

  2020cites this paper
• EGFR/FOXO3a/BIM signaling pathway determines chemosensitivity of BMP4-differentiated glioma stem cells to temozolomide

  2020cites this paper
• Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4–Sox2 complex decoy oligodeoxynucleotides

  2020cites this paper
• Recent Advances in Targeting of Breast Cancer Stem Cells Based on Biological Concepts and Drug Delivery System Modification

  2020cites this paper
• Temozolomide-Induced RNA Interactome Uncovers Novel LncRNA Regulatory Loops in Glioblastoma

  2020cites this paper
• Molecular hydrogen induces metabolic reprogramming to promote differentiation of glioma stem cells

  2020cites this paper
• Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents

  2020cites this paper
• Cell Reversal From a Differentiated to a Stem-Like State at Cancer Initiation

  2020cites this paper
• Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro

  2020influential citation
• Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs

  2020cites this paper
• XAB2 prevents abortive recombinational repair of replication-associated DNA double-strand breaks and its loss is synthetic lethal with RAD52 inhibition

  2020cites this paper
• Phenotypic mapping of pathological crosstalk between glioblastoma and innate immune cells by synthetic genetic tracing.

  2020cites this paper
• CloneSeq: A Highly Sensitive Single-cell Analysis Platform for Comprehensive Characterization of Cells from 3D Culture

  2020cites this paper
• Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors

  2020cites this paper
• Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy

  2020cites this paper
• Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas

  2020cites this paper
• Brain Malignancies: Cancer Cell Trafficking in and out of the Niches.

  2020cites this paper
• Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells

  2020influential citation
• HPV+ve/−ve oral-tongue cancer stem cells: A potential target for relapse-free therapy

  2020cites this paper
• Cancer cells stemness: A doorstep to targeted therapy.

  2020cites this paper
• Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

  2020cites this paper
• Identification of Caffeic Acid Phenethyl Ester (CAPE) as a Potent Neurodifferentiating Natural Compound That Improves Cognitive and Physiological Functions in Animal Models of Neurodegenerative Diseases

  2020cites this paper
• Gold(I) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancer.

  2020cites this paper
• represent relevant patient avatars for precision medicine

  2020cites this paper
• FASN Is a Biomarker Enriched in Malignant Glioma-Derived Extracellular Vesicles

  2020cites this paper
• High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma

  2020cites this paper
• Correction: Gold(I) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancer.

  2020cites this paper
• Primary and recurrent glioma patient-derived orthotopic xenografts (PDOX) represent relevant patient avatars for precision medicine

  2020cites this paper
• Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.

  2019cites this paper
• Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide

  2019cites this paper
• Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma

  2019cites this paper
• Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood–Brain Barrier

  2019cites this paper
• A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production.

  2019influential citation
• Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation.

  2019cites this paper
• Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment

  2019cites this paper
• Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation

  2019cites this paper